2020 Global Nucleic Acid Testing/NAT Lab and POC Market: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

April 2020 | 1398 pages | ID: 2ED154B33C6EEN
Venture Planning Group

Abstracts

This unique seven-country report, 1,398-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.

Highlights

• Business and technological trends in seven major markets
• Five-year test volume and sales forecasts
• Market shares of leading competitors
• Feature comparison of major analyzers
• Profiles of market players and start-up firms developing innovative technologies and products
• Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

• France
• Germany
• Italy
• Japan
• Spain
• UK
• USA

Worldwide Market Overview

• Laboratories performing DNA sequencing and NAT by country and market segment.
• Five-year test volume and sales projections by country.

Market Segmentation Analysis

• Sales and market shares of major suppliers of NAT reagent kits and components.
• Five-year test volume and sales forecasts for major applications, including:
  • Infectious Diseases
  • Forensic Testing
  • Cancer
  • Paternity Testing/HLA Typing
  • Genetic Diseases
  • Others
• Five-year test volume and sales projections for over 30 NAT assays.
• A comprehensive analysis of the sequencing market, by country and laboratory segment, including:
  • Industrial
  • Academic
  • Government
  • Commercial
• Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.

Product/Technology Review

• Comparison of leading NAT analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.
• Extensive review of NAT technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
  • PCR
  • bDNA
  • SDA
  • NASBA
  • SSSR, and others
  • LCR
• Worldwide listings of companies, universities and research centers developing new NAT technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Comprehensive listings of companies developing and marketing NAT products, by test and application.

Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data base was conducted.

Contains 1,398 pages and 194 tables

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. WORLDWIDE MARKET AND TECHNOLOGY REVIEW

A. DNA Sequencing
$nbsp;$nbsp;1. Introduction
$nbsp;$nbsp;2. Sequencing Methods
$nbsp;$nbsp;3. Autoradiography
$nbsp;$nbsp;4. The Human Genome Project
$nbsp;$nbsp;5. Sequencing Automation
$nbsp;$nbsp;6. Image Scanners
$nbsp;$nbsp;7. Fluorescent Detection
$nbsp;$nbsp;8. Gene Profiling
$nbsp;$nbsp;9. Gene Expression
$nbsp;$nbsp;10. Polymorphism Screening
$nbsp;$nbsp;11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
$nbsp;$nbsp;1. Basic Principles
$nbsp;$nbsp;2. Probe Preparation
$nbsp;$nbsp;3. The DNA Probe Test
$nbsp;$nbsp;4. Test Formats
$nbsp;$nbsp;5. Labeling Techniques
$nbsp;$nbsp;6. Amplification Methods
C. Detection Technologies
$nbsp;$nbsp;1. Radioactive Methods
$nbsp;$nbsp;$nbsp;$nbsp;a. Overview
$nbsp;$nbsp;$nbsp;$nbsp;b. Major Isotopes
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;P-32
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;S-35
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;H-3
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;I-125
$nbsp;$nbsp;2. Non-Isotopic Methods
$nbsp;$nbsp;$nbsp;$nbsp;a. Enzymatic Labels
$nbsp;$nbsp;$nbsp;$nbsp;b. Chemical Labeling
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Indirect Chemical Labeling
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Direct Chemical Labeling
$nbsp;$nbsp;$nbsp;$nbsp;c. Fluorescence
$nbsp;$nbsp;$nbsp;$nbsp;d. Chemiluminescence
$nbsp;$nbsp;$nbsp;$nbsp;e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
$nbsp;$nbsp;1. Abbott LCx
$nbsp;$nbsp;2. Beckman Coulter/Biomek FK
$nbsp;$nbsp;3. BD Viper System with XTR Technology
$nbsp;$nbsp;4. BD Innova
$nbsp;$nbsp;5. Becton Dickinson SDA
$nbsp;$nbsp;6. bioMerieux NucliSENS easyMAG
$nbsp;$nbsp;7. bioMerieux NucliSENS easyQ and MiniMAG
$nbsp;$nbsp;8. Bio-Rad GeneScope
$nbsp;$nbsp;9. Cepheid GeneXpert
$nbsp;$nbsp;10. Curetis Unyvero
$nbsp;$nbsp;11. GenMark Dx eSensor XT-8
$nbsp;$nbsp;12. Hologic/Gen-Probe Panther
$nbsp;$nbsp;13. Hologic/Gen-Probe Tigris/DTS
$nbsp;$nbsp;14. HTG Molecular Edge
$nbsp;$nbsp;15. Life Technologies QuantStudio Dx
$nbsp;$nbsp;16. Qiagen QIAsymphony RGQ
$nbsp;$nbsp;17. Roche Cobas Amplicor
$nbsp;$nbsp;18. Roche Cobas TaqMan
$nbsp;$nbsp;19. Roche Cobas TaqMan
$nbsp;$nbsp;20. Roche Cobas TaqMan AmpliPrep
$nbsp;$nbsp;21. Roche LighCycler
$nbsp;$nbsp;22. Roche Cobas 4800
$nbsp;$nbsp;23. Roche Cobas s
$nbsp;$nbsp;24. Siemens Versant
$nbsp;$nbsp;25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Liquid Transportation and Mixing
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Separation
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Reaction
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Detection
F. Pharmacogenomics
G. Major Applications
$nbsp;$nbsp;1. Microbiology/Infectious Diseases
$nbsp;$nbsp;$nbsp;$nbsp;a. Overview
$nbsp;$nbsp;$nbsp;$nbsp;b. Major Infectious Diseases
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Adenovirus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Aeromonas
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Anthrax/Bacillus Anthracis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Arboviruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Babesiosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Blastocystis Hominis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Brucella
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Campylobacter
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Candida
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Chagas Disease
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Chancroid
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Chlamydia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Clostridium Difficile
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Coronaviruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Coxsackieviruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Creutzfeldt-Jakob’s Disease
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Cryptosporidium Parvum
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Cyclospora Cayetanensis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Cytomegalovirus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Ebola Virus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;E. Coli
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;EchoVirus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Encephalitis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Enteroviruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Epstein-Barr Virus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Giardia Lamblia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Gonorrhea
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Granuloma Inguinale
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Hantavirus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Helicobacter Pylori
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Herpes Simplex Virus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Human Herpes Virus-6 (HHV-6)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Influenza Viruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Legionella
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Lyme Disease
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Lymphogranuloma Venereum (LGV)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Malaria
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Measles (Rubeola)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Meningitis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Microsporidium
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Mononucleosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Mumps
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Mycoplasma
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Papillomaviruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Parvovirus B19
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Pneumonia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Polyomaviruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Pseudomonas Aeruginosa
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Rabies
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Respiratory Syncytial Virus (RSV)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Rhinoviruses
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Rotavirus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Rubella
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Salmonellosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Septicemia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Shigellosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Staphylococcus Aureus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Streptococci
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Syphilis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Toxoplasmosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Trichomonas Vaginalis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Tuberculosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Vibrio
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;West Nile Virus
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Yersinia
$nbsp;$nbsp;2. Cancer Testing
$nbsp;$nbsp;$nbsp;$nbsp;a. Overview
$nbsp;$nbsp;$nbsp;$nbsp;b. Major Cancer Types
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Prostate
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Lung
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Colon and Rectum
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Breast
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Skin
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Uterine
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Leukemia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Oral
$nbsp;$nbsp;$nbsp;$nbsp;c. Oncogenes
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Abl/abl-bcr
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;AIB1
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;BCL-2
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;BRCA1
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;CD44
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;C-fos
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;C-myb
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;C-myc
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;CYP17
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Erb-B
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;HPC1
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;N-myc
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;P40
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;P51
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;P53
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;PIK3CA
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;PTI-1
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Ras
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Reg
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Sis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Src
$nbsp;$nbsp;3. Genetic Diseases
$nbsp;$nbsp;$nbsp;$nbsp;a. Overview
$nbsp;$nbsp;$nbsp;$nbsp;b. Nucleic Acid Amplification
$nbsp;$nbsp;$nbsp;$nbsp;c. Chromosome Imaging
$nbsp;$nbsp;$nbsp;$nbsp;d. Genomics Technologies
$nbsp;$nbsp;$nbsp;$nbsp;e. Proteomics Technologies
$nbsp;$nbsp;$nbsp;$nbsp;f. Current Pharmacogenomic Tests
$nbsp;$nbsp;$nbsp;$nbsp;g. Future Pharmacogenomic Testing
$nbsp;$nbsp;$nbsp;$nbsp;h. Major Diseases
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Achondroplasia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Autosomal Dominant Polycystic Kidney Disease
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Cancer
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Cosmetogenomics
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Cystic Fibrosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Down's Syndrome
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Duchenne and Becker Muscular Dystrophy
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Factor V (Leiden)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Factor IX Deficiency
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Fragile X Syndrome
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Heart Disease
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Hemochomatosis
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Hemophilia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Huntington's Disease
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Maternal-Fetal Incompatibility
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Multiple Endocrine Neoplasia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Phenylketonuria (PKU)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Polycystic Kidney Disease (PKD)
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Prenatal Screening
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Retinitis Pigmentosa
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Retinoblastoma
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Sickle Cell Anemia
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Spinal Muscular Atrophy
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Vitamin B12 Metabolism
$nbsp;$nbsp;$nbsp;$nbsp;i. Social Issues and Concerns
$nbsp;$nbsp;4. Forensic Testing
$nbsp;$nbsp;$nbsp;$nbsp;a. Overview
$nbsp;$nbsp;$nbsp;$nbsp;b. Multilocus and Single Locus Probes
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Multilocus Probes
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Single Locus Probes
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;PCR and RFLP
$nbsp;$nbsp;$nbsp;$nbsp;c. The FBI
$nbsp;$nbsp;$nbsp;$nbsp;d. DNA Profile Data Banks
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;U.S.A.
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;U.K.
$nbsp;$nbsp;$nbsp;$nbsp;e. Judicial Implementation
$nbsp;$nbsp;$nbsp;$nbsp;f. Major Crime Categories
$nbsp;$nbsp;$nbsp;$nbsp;g. Factors Contributing to the DNA Probe Market Expansion
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Technology Availability
$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;$nbsp;Use of Hair as Evidence
$nbsp;$nbsp;$nbsp;$nbsp;h. Wildlife Forensics
$nbsp;$nbsp;5. Paternity Testing/HLA Typing
$nbsp;$nbsp;6. Other Applications
$nbsp;$nbsp;$nbsp;$nbsp;a. Disease Susceptibility Testing
$nbsp;$nbsp;$nbsp;$nbsp;b. Cardiovascular Diseases
$nbsp;$nbsp;$nbsp;$nbsp;c. Diabetes
$nbsp;$nbsp;$nbsp;$nbsp;d. Alzheimer's Disease
$nbsp;$nbsp;$nbsp;$nbsp;e. Periodontal Disease
$nbsp;$nbsp;$nbsp;$nbsp;f. Plasma Purification
$nbsp;$nbsp;$nbsp;$nbsp;g. Organ Transplantation
$nbsp;$nbsp;$nbsp;$nbsp;h. Water Contamination
$nbsp;$nbsp;$nbsp;$nbsp;i. Other
H. Competing/complementing
$nbsp;$nbsp;1. Monoclonal Antibodies/Immunoassays
$nbsp;$nbsp;2. RNA Probes
$nbsp;$nbsp;3. Two-Dimensional Electrophoresis
$nbsp;$nbsp;4. Flow Cytometry

VII. WORLDWIDE MARKET OVERVIEW

$nbsp;$nbsp;1. Business Environment
$nbsp;$nbsp;2. Market Structure
$nbsp;$nbsp;3. Market Size and Growth

VIII. FRANCE MOLECULAR DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

IX. GERMANY MOLECULAR DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

X. ITALY MOLECULAR DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XI. JAPAN MOLECULAR DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XII. SPAIN MOLECULAR DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XIII. U.K. MOLECULAR DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XIV. U.S.A. MOLECULAR DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XV. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

XVI. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING MOLECULAR DIAGNOSTIC TECHNOLOGIES

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Malaria Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases
Worldwide, Laboratories Performing DNA Sequencing by Country
Worldwide, Molecular Diagnostics Market Potential
Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast by Country
Worldwide, Molecular Diagnostics Market Forecast by Country
France
Molecular Diagnostics Test Volume And Sales By Major Application
France
Laboratories Performing DNA Sequencing By Market Segment
France
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
France
Molecular Diagnostics Test Volume By Major Application
France
Major Infectious Disease Test Volume by Assay
France
Major Infectious Disease Test Volume by Method
France
Molecular Diagnostics Market By Major Application
France
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
France
Major Infectious Disease Diagnostics Market by Assay
France
AIDS Testing Market Estimated Sales by Major Supplier
France
Adenovirus Testing Market Estimated Sales by Major Supplier
France
Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
France
CMV Testing Market Estimated Sales by Major Supplier
France
Hepatitis C Testing Market Estimated Sales by Major Supplier
France
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France
Herpes Testing Market Estimated Sales by Major Supplier
France
Influenza Testing Market Estimated Sales by Major Supplier
France
Meningitis Testing Market Estimated Sales by Major Supplier
France
Mycoplasma Testing Market Estimated Sales by Major Supplier
France
RSV Testing Market Estimated Sales by Major Supplier
France
Shigella Testing Market Estimated Sales by Major Supplier
Germany
Molecular Diagnostics Test Volume And Sales By Major Application
Germany
Laboratories Performing DNA Sequencing By Market Segment
Germany
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Germany
Molecular Diagnostics Test Volume By Major Application
Germany
Major Infectious Disease Test Volume by Assay
Germany
Major Infectious Disease Test Volume by Method
Germany
Molecular Diagnostics Market By Major Application
Germany
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Germany
Major Infectious Disease Diagnostics Market by Assay
Germany
AIDS Testing Market Estimated Sales by Major Supplier
Germany
CMV Testing Market Estimated Sales by Major Supplier
Germany
EBV Testing Market Estimated Sales by Major Supplier
Germany
Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany
Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany
Herpes Testing Market Estimated Sales by Major Supplier
Germany
Influenza Testing Market Estimated Sales by Major Supplier
Germany
Meningitis Testing Market Estimated Sales by Major Supplier
Germany
Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany
Pneumonia Testing Market Estimated Sales by Major Supplier
Germany
RSV Testing Market Estimated Sales by Major Supplier
Germany
Rotavirus Testing Market Estimated Sales by Major Supplier
Italy
Molecular Diagnostics Test Volume And Sales By Major Application
Italy
Laboratories Performing DNA Sequencing By Market Segment
Italy
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Italy
Molecular Diagnostics Test Volume By Major Application
Italy
Major Infectious Disease Test Volume by Assay
Italy
Major Infectious Disease Test Volume by Method
Italy
Molecular Diagnostics Market By Major Application
Italy
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Italy
Major Infectious Disease Diagnostics Market by Assay
Italy
AIDS Testing Market Estimated Sales by Major Supplier
Italy
CMV Testing Market Estimated Sales by Major Supplier
Italy
Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy
Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy
Herpes Testing Market Estimated Sales by Major Supplier
Italy
Influenza Testing Market Estimated Sales by Major Supplier
Italy
Meningitis Testing Market Estimated Sales by Major Supplier
Italy
Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy
RSV Testing Market Estimated Sales by Major Supplier
Japan
Molecular Diagnostics Test Volume And Sales By Major Application
Japan
Laboratories Performing DNA Sequencing By Market Segment
Japan
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Japan
Molecular Diagnostics Test Volume By Major Application
Japan
Major Infectious Disease Test Volume by Assay
Japan
Major Infectious Disease Test Volume by Method
Japan
Molecular Diagnostics Market By Major Application
Japan
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Japan
Major Infectious Disease Diagnostics Market by Assay
Japan
AIDS Testing Market Estimated Sales by Major Supplier
Japan
Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan
CMV Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan
Herpes Testing Market Estimated Sales by Major Supplier
Japan
Meningitis Testing Market Estimated Sales by Major Supplier
Japan
Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan
Pneumonia Testing Market Estimated Sales by Major Supplier
Japan RSV Testing Market Estimated Sales by Major Supplier
Japan
Shigella Testing Market Estimated Sales by Major Supplier
Spain
Molecular Diagnostics Test Volume And Sales By Major Application
Spain
Laboratories Performing DNA Sequencing By Market Segment
Spain
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Spain
Molecular Diagnostics Test Volume By Major Application
Spain
Major Infectious Disease Test Volume by Assay
Spain
Major Infectious Disease Test Volume by Method
Spain
Molecular Diagnostics Market By Major Application
Spain
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
Spain
Major Infectious Disease Diagnostics Market by Assay
Spain
AIDS Testing Market Estimated Sales by Major Supplier
Spain
Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain
CMV Testing Market Estimated Sales by Major Supplier
Spain
Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain
Herpes Testing Market Estimated Sales by Major Supplier
Spain
Influenza Testing Market Estimated Sales by Major Supplier
Spain
Meningitis Testing Market Estimated Sales by Major Supplier
Spain
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K.
Molecular Diagnostics Test Volume And Sales By Major Application
U.K.
Laboratories Performing DNA Sequencing By Market Segment
U.K.
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
U.K.
Molecular Diagnostics Test Volume By Major Application
U.K.
Major Infectious Disease Test Volume by Assay
U.K.
Major Infectious Disease Test Volume by Method
U.K.
Molecular Diagnostics Market By Major Application
U.K.
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.K.
Major Infectious Disease Diagnostics Market by Assay
U.K.
AIDS Testing Market Estimated Sales by Major Supplier
U.K.
Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K.
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K.
Influenza Testing Market Estimated Sales by Major Supplier
U.K.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.K.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
Molecular Diagnostics Test Volume And Sales By Major Application
U.S.A.
Laboratories Performing DNA Sequencing By Market Segment
U.S.A.
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
U.S.A.
Molecular Diagnostics Test Volume by Major Application
U.S.A.
Major Infectious Disease Test Volume by Assay
U.S.A.
Major Infectious Disease Test Volume by Method
U.S.A.
Molecular Diagnostics Market By Major Application
U.S.A.
Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers
U.S.A.
Major Infectious Disease Diagnostics Market by Assay
U.S.A.
AIDS Testing Market Estimated Sales by Major Supplier
U.S.A.
Adenovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Chlamydia/Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A.
CMV Testing Market Estimated Sales by Major Supplier
U.S.A.
Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
EBV Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A.
HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A.
Herpes Testing Market Estimated Sales by Major Supplier
U.S.A.
Influenza Testing Market Estimated Sales by Major Supplier
U.S.A.
Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A.
Rabies Testing Market Estimated Sales by Major Supplier
U.S.A.
RSV Testing Market Estimated Sales by Major Supplier
U.S.A.
Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
West Nile Virus Nat Market Reagent Sales by Major Supplier